ATHIRA

Fosgonimeton

This clinical trial examines the long-term tolerability of Fosgonimeton (ATH-1017) over an additional 4-year period in subjects with mild to moderate Alzheimer’s disease.  This trial is an extension of Study ATH-1017-AD-0201 and Study ATH-1017-AD-0202.

Status: ACTIVE, NOT RECRUITING

Application











    All information provided is confidential and will not be given or sold to any other agency without prior consent.